Rosiglitazone Suppresses Angiogenesis in Multiple Myeloma via Downregulation of Hypoxia-Inducible Factor-1α and Insulin-Like Growth Factor-1 mRNA Expression

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2014.2407